Sponsor:
Acurx Pharmaceuticals Inc.
Code:
NCT07513285
Conditions
Clostridium Difficile Infection Recurrence
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ibezapolstat
Brief summary:
Conditions
Clostridium Difficile Infection Recurrence
Study ID
NCT07513285
Start date
Sep 25, 2026
Status verified date
Oct, 2026
Completion date
Nov 24, 2027
Anticipated
Primary completion date
Sep 29, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
20 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Ibezapolstat
Interventions
Ibezapolstat
Primary outcome measure
Central contacts
Dee Rodriguez
dee.rodriguez@acurxpharma.comLocations
Gastroenterolgy Center of Conneticut
Recruiting
Hamden, Connecticut, United States, 06518
Florida International Medical Research
Recruiting
Coral Gables, Florida, United States, 33134
L&A Morales Healthcare, Inc
Recruiting
Hialeah, Florida, United States, 33012
San Marcus Research Clinc, Inc
Recruiting
Miami Lakes, Florida, United States, 33014
Belis Delgado, MD PA
Recruiting
Miami Springs, Florida, United States, 33166
Infectious Disease Consultants of Georgia
Recruiting
Athens, Georgia, United States, 30606
Snake River Research PLLC
Recruiting
Idaho Falls, Idaho, United States, 83404
Endevour Health
Recruiting
Skokie, Illinois, United States, 60077
Newton-Wellesley Hospital
Recruiting
Newton, Massachusetts, United States, 02462
University of Massachusetts Memorial Healthcare
Recruiting
Worcester, Massachusetts, United States, 01655
Henry Ford Hospital
Recruiting
Detroit, Michigan, United States, 48202
DiGiovanna Institute for Medical Education and Research
Recruiting
Massapequa, New York, United States, 11758
Gastroenterology Associates of the Piedmont, PA
Recruiting
Winston-Salem, North Carolina, United States, 27103
Romano, Pontzer & Associated
Recruiting
Pittsburgh, Pennsylvania, United States, 15215
Southern Star Research Institute, LLC
Recruiting
San Antonio, Texas, United States, 78229
Sponsor
Acurx Pharmaceuticals Inc.
Last update posted
Nov 13, 2026
Last verified
Oct, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-21. This information was provided to ClinicalTrials.gov by Acurx Pharmaceuticals Inc. on 2026-11-13. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.